Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Scopus BioPharma Inc..
Scopus BioPharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Scopus BioPharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Scopus BioPharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Scopus BioPharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Scopus BioPharma Inc. and all latest updates of the company are provided.
The 2025 version of Scopus BioPharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Scopus BioPharma Inc.- Key Facts
2.2 Scopus BioPharma Inc.- Geographic Locations
2.3 Scopus BioPharma Inc.- Subsidiaries and Affiliates
2.4 Scopus BioPharma Inc.- Business Divisions
2.5 Scopus BioPharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Scopus BioPharma Inc. Strategic Analysis Review
3.1 Scopus BioPharma Inc.- Key Strategies
3.2 Scopus BioPharma Inc.- Company Outlook Statement
3.3 Scopus BioPharma Inc.- SWOT Analysis
3.3.1 Scopus BioPharma Inc.- Key Strengths
3.3.2 Scopus BioPharma Inc.- Key Weaknesses
3.3.3 Scopus BioPharma Inc.- Potential Opportunities
3.3.4 Scopus BioPharma Inc.- Potential Threats
3.4 Scopus BioPharma Inc.- Key Competitors
4. Business Description of the Company
4.1 Scopus BioPharma Inc.- Business Overview
4.2 Scopus BioPharma Inc.- Operations by Segment
5 Products and Services Details
5.1 Scopus BioPharma Inc.- Key Products
5.2 Scopus BioPharma Inc.- Key Service Areas
5.3 Scopus BioPharma Inc.- Key Brands
6 Company Developments
6.1 Scopus BioPharma Inc.- Company History
6.2 Scopus BioPharma Inc.- Latest Developments
7 Financial Analysis
7.1 Scopus BioPharma Inc.- Income Statements
7.2 Scopus BioPharma Inc.- Balance Sheet
7.3 Scopus BioPharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Scopus BioPharma Inc.- Direct Competitors
8.2 Scopus BioPharma Inc.- Competitor Financial Ratios comparison
8.3 Scopus BioPharma Inc.- Competitor Stock Charts Comparison
8.4 Scopus BioPharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!